|
Volumn 42, Issue 5, 2000, Pages 829-830
|
Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
CASE REPORT;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INFUSION;
FEMALE;
HUMAN;
PRIORITY JOURNAL;
PSORIASIS;
REBOUND;
REMISSION;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
DERMATOLOGIC AGENTS;
FEMALE;
HUMANS;
MIDDLE AGED;
PSORIASIS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0034023433
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1067/mjd.2000.105948 Document Type: Article |
Times cited : (220)
|
References (5)
|